Pacira BioSciences Files Proxy Statement
Ticker: PCRX · Form: DEFA14A · Filed: Mar 14, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | DEFA14A |
| Filed Date | Mar 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, corporate-governance
TL;DR
Pacira BioSciences filed its proxy statement, no fee needed. Get ready for shareholder votes.
AI Summary
Pacira BioSciences, Inc. filed a Definitive Proxy Statement (DEFA14A) on March 14, 2025, related to soliciting materials under Section 240.14a-12. The filing indicates no fee was required for this submission. The company, previously known as Pacira Pharmaceuticals, Inc., is headquartered in Brisbane, California.
Why It Matters
This filing is a routine proxy statement, indicating the company is preparing for shareholder meetings or votes, which could involve important corporate decisions.
Risk Assessment
Risk Level: low — This is a standard regulatory filing (DEFA14A) and does not inherently present new risks to investors.
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- 0001396814 (company) — Central Index Key
- 2000 Sierra Point Parkway, Suite 900, Brisbane, CA 94005 (company) — Business Address
- Pacira Pharmaceuticals, Inc. (company) — Former Company Name
- 20101029 (date) — Date of Name Change
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a Definitive Proxy Statement filed with the SEC, used by companies to solicit proxies from shareholders for an upcoming meeting or vote.
When was this specific DEFA14A filed?
This DEFA14A filing was filed on March 14, 2025.
Does this filing require a fee?
No, the filing explicitly states 'No fee required.'
What is Pacira BioSciences, Inc.'s primary business classification?
Pacira BioSciences, Inc. is classified under Standard Industrial Classification (SIC) code 2834, which is 'Pharmaceutical Preparations'.
Has Pacira BioSciences, Inc. always been known by this name?
No, the company has had previous names, including Pacira Pharmaceuticals, Inc., PACIRA INC, and Blue Acquisition Corp, with the most recent name change from Pacira Pharmaceuticals, Inc. occurring on October 29, 2010.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 14, 2025 regarding Pacira BioSciences, Inc. (PCRX).